Control of postprandial hyperglycemia by oral administration of the sea anemone mucus-derived α-amylase inhibitor (magnificamide)

Diabetes mellitus is a serious threat to human health in both developed and developing countries. Optimal disease control requires the use of a diet and a combination of several medications, including oral hypoglycemic agents such as α-glucosidase inhibitors. Currently, the arsenal of available drug...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Biomedicine & pharmacotherapy 2023-12, Vol.168, p.115743-115743, Article 115743
Hauptverfasser:	Sintsova, Oksana, Popkova, Darya, Kalinovskii, Aleksandr, Rasin, Anton, Borozdina, Natalya, Shaykhutdinova, Elvira, Klimovich, Anna, Menshov, Alexander, Kim, Natalia, Anastyuk, Stanislav, Kusaykin, Mikhail, Dyachenko, Igor, Gladkikh, Irina, Leychenko, Elena
Format:	Artikel
Sprache:	eng
Schlagworte:	Diabetes Hyperglycemia Metabolism Sea anemone Venom α-amylase inhibitor
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!